x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

pharmaphorum Podcast

pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for

science life sciences

All Episodes

12:51

Looking to gene therapy for ocular diseases, with...

pharmaphorum Podcast ·

2026/04/08

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh spoke with Lance Baldo, CEO of Beacon Therapeutics, a clinical-stage biotechnology company harnessing the transformative power of gene therapy to deliver meaningful outcomes for severe ocular diseases.Baldo discusses the ocular disease landscape, as well as Beacon’s work targeting X-linked retinitis pigmentosa (XLRP) and geographic atrophy (GA), and what the future could look like in terms of innovation in this field. You

en-us

13:40

Creating what nature has not from AI and...

pharmaphorum Podcast ·

2026/03/31

In a new episode of the pharmaphorum podcast, recorded at BIO-Europe Spring in Lisbon, Portugal, web editor Nicole Raleigh spoke with Kashif Sadiq, founder and CEO of DenovAI Biotech, a company that believes humanity is on the cusp of a protein design revolution that stands to transform both human health and the world around us.Sadiq discusses the company's springboard from AION Labs - with a first-of-its-kind alliance of AstraZeneca, Merck, Pfizer, Teva, the Israel Biotech Fund, Amiti Ventures,

en-us

11:20

On collaboration, computational chemistry, and...

pharmaphorum Podcast ·

2026/03/25

At BIO-Europe Spring 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Dr Olga Nissan, vice president of business development at Evogene, a computational chemistry company, specialising in the generative design of small molecules for the pharmaceutical and agricultural industries.Nissan discusses recent developments at Evogene, including its extended collaboration with Google Cloud to develop and integrate AI agents into Evogene’s ChemPass AI platform, as well as its collaboration with

en-us

19:11

Making AI work where it matters, with Rob DiCicco

pharmaphorum Podcast ·

2026/03/17

In a new pharmaphorum podcast, web editor Nicole Raleigh was joined by Rob DiCicco, vice president of portfolio management at Transcelerate Biopharma Inc, for a conversation on the barriers and the breakthroughs in making AI work in drug development and clinical trials.DiCicco discusses why AI adoption in clinical trials is so different from preclinical research and development, as well as how synthetic control arms and in silico modelling reshape trial design, and he touches upon the need for

en-us

24:39

Treating genetic disease at scale with tRNA, with...

pharmaphorum Podcast ·

2026/03/10

Genetic diseases are notoriously challenging to treat, especially when each condition requires a tailored approach. With over 10,000 known genetic disorders, developing individual therapies for each one has been an immense hurdle, particularly for rare diseases affecting small patient populations. But what if there was a way to address multiple conditions simultaneously, using a single, universal approach?In today’s episode of the pharmaphorum podcast, Michelle Werner, CEO of Alltrna, discusses her

en-us

25:05

AI in clinical development & ‘white space’, with...

pharmaphorum Podcast ·

2026/03/03

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Andrew Mackinnon, senior vice president and executive general manager at Medable, about leveraging AI to transform clinical development and accelerate lifesaving therapies to patients.Mackinnon discusses ‘white space’ in R&D, about integrating generative and agentic AI with human-in-the-loop oversight while prioritising patient safety and regulatory, and how all this advances health equity for underserved

en-us

12:18

Collaboration & personalisation in rare disease R&D,...

pharmaphorum Podcast ·

2026/02/26

For 30 years, the AOP Health Group has been dedicated to developing innovative solutions to address unmet medical needs, particularly in the fields of rare diseases and intensive care medicine, and notably in cardiology and pulmonology, as well as haemato-oncology and advanced therapies. As Rare Disease Day approaches, in a special episode of the pharmaphorum podcast, sponsored by AOP Health, we spoke with Melissa Fellner, VP of Global Therapeutic Areas, Commercial Operations, at AOP Health, to

en-us

24:10

Policy in Focus: Unpacking GLOBE, GUARD, and TrumpRx...

pharmaphorum Podcast ·

2026/02/24

Slowly but surely – and just in time for the State of the Union – the full picture of the Trump Administration’s Most-Favoured Nations drug pricing policy is coming into focus. At the end of last year, CMS published the draft guidance for its GLOBE and GUARD pricing models, which establish MFN pricing in Medicare Part B and Part D, respectively. And earlier this month TrumpRx – the government’s promised patient-facing discount portal – finally went live. On today’s podcast, Jonah Comstock is joined

en-us

17:36

On JPM2026 and healthcare investment today, with...

pharmaphorum Podcast ·

2026/02/17

Following his return from San Francisco and the JP Morgan Healthcare conference last month, editor-in-chief Jonah Comstock sat down with pharmaphorum web editor Nicole Raleigh to discuss what he heard and learned on the ground in California.2026 marked the 44th year of the annual meeting: Comstock shares his top insights, goes into the details from the panel he moderated at the Informa Biotech Showcase, and suggests his key takeaway from this year’s conference. You can listen to episode 245 of

en-us

12:30

On addressing drug waste and ensuring access, with...

pharmaphorum Podcast ·

2026/02/10

The rising cost of drugs in 2025 was driven by several factors, including inflation, supply chain issues, and the demand for specialty drugs – straining already overburdened health systems.In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Jeff Harper, head of product at IntelliGuard, about these pressing issues and what hospitals can expect as we progress further into 2026. The conversation also explores the role digital health technologies like RFID and predictive analytics

en-us

25:01

From Buzzword to Strategy: Reverba Global Talks...

pharmaphorum Podcast ·

2026/02/05

The term "omnichannel engagement" has become embedded in today’s healthcare conversations. Yet the biopharmaceutical industry often approaches it superficially – treating it as a trendy buzzword instead of a meaningful strategy for connecting with the sector's two most vital audiences: patients and healthcare providers (HCPs).In this episode of the pharmaphorum podcast, developed in partnership with Reverba Global, editor-in-chief Jonah Comstock sits down with Cheryl Lubbert, co-founder and CEO of

en-us

16:10

On quality data for quality learnings, with Lisa Sims

pharmaphorum Podcast ·

2026/02/03

Outdated training and behaviours impact patient outcomes and can lead to patient risk. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Lisa Sims, executive director of learning strategy & operations at Novartis, for a conversation on modern training for pharma and how AI and data – quality data – can help personalise learning at scale. You can listen to episode 243 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and

en-us

7:50

JPM2026: Broadening AI drug discovery to include the...

pharmaphorum Podcast ·

2026/01/27

At the JP Morgan Healthcare conference this year, a lot of the discourse around AI drug discovery focused on making the leap from purely in silico drug discovery operations to real-world operations that are able to incorporate wet lab data in an iterative way.This is easily said, but to do it requires innovating new processes and infrastructures. On the sidelines of the show, pharmaphorum’s Jonah Comstock caught up with Yann Gaston-Mathe, founder and CEO of Iktos, an AI drug discovery company that

en-us

21:43

On AI and equity in the cancer setting, with Mohit...

pharmaphorum Podcast ·

2026/01/20

The global impact of digital transformation in the last few decades cannot be understated. And now, of course, artificial intelligence (or AI) is making headlines for its potential to transform lives. In a new pharmaphorum podcast, Deep Dive editor Eloise McLennan speaks with Mohit Manrao, SVP, head of US oncology at AstraZeneca, and president of the AstraZeneca Foundation. The conversation explores the application of AI in cancer care, some of the most promising potential applications of AI in the

en-us

12:07

JPM2026: AI diagnostics and translational research,...

pharmaphorum Podcast ·

2026/01/15

On-site on the sidelines of JP Morgan Healthcare conference in San Francisco this year, pharmaphorum editor-in-chief Jonah Comstock sat down with Andrew Beck, co-founder and CEO at PathAI.The conversation covers what PathAI has been up to lately in AI within diagnostics in pathology, explores what’s been discussed on the ground at the conference, and also touches upon equality and access to precision diagnostics. Additionally, Beck notes the company’s work in prospective clinical trials in life

en-us

24:02

Shaping the future of immunodeficiency care, with Dr...

pharmaphorum Podcast ·

2026/01/06

An increasing prevalence of immunodeficiency and autoimmune disorders has led to increasing demand for plasma-derived immunoglobulin therapies and a need for scalable and sustainable treatment solutions.In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Jörg Schüttrumpf, MD, PhD, Chief Scientific Innovation Officer of Grifols and Chief Executive Officer at Biotest, a Grifols company. The conversation explores advancing immunoglobulin (or IG) treatment for immune disorders,

en-us

14:34

Aligning with national efforts to modernise cancer...

pharmaphorum Podcast ·

2025/12/30

A liquid biopsy is a blood test that detects signs of cancerous tumors, including tumour cells and cancer cell DNA.In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Andrew Newland, CEO of ANGLE, about why live cell liquid biopsies should become standard in oncology. Newland explains how current US FDA-approved tests can detect some types of advanced cancers, predict prognosis, and help healthcare providers make treatment decisions. And importantly, Newland describes how live cell

en-us

15:47

Rethinking prescription drug affordability, with...

pharmaphorum Podcast ·

2025/12/29

It goes without saying that drug pricing and accessibility in the United States are complex indeed. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Vinay Patel, an innovative pharmacist who's set out to transform the healthcare industry, about these intricacies. Patel discusses some intriguing stories about crafting innovative solutions for employers, revitalising struggling independent pharmacies, and implementing hybrid care models that can make healthcare more attainable for

en-us

17:00

An AI supercomputer and discovering next-gen brain...

pharmaphorum Podcast ·

2025/12/23

Gefion is Denmark’s first AI supercomputer, named after a goddess in Danish mythology. It is operated by the Danish Centre for AI Innovation (DCAI), a company established with funding from the Novo Nordisk Foundation, the world’s wealthiest charitable foundation, as well as the Export and Investment Fund of Denmark.In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tarek Samad, Lundbeck’s senior vice president and head of research, for a conversation on AI – specifically,

en-us

19:15

On genomics, NGS, and doing much more good than bad,...

pharmaphorum Podcast ·

2025/12/22

Illumina innovative sequencing and array technologies are fuelling groundbreaking advancements in life sciences research, translational and consumer genomics, and molecular diagnostics. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Markus Vossman, Germany general manager at Illumina, about innovative genomic applications and projects in the region. Vossman discusses the genomics landscape, as well as next-generation sequencing (or NGS), and the Model Project, a large-scale

en-us

333 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter